{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:50:47Z","timestamp":1789671047884,"version":"4.0.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Research Counsel of Norway"},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.08.094","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T16:37:02Z","timestamp":1442680622000},"page":"6988-6996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8+-mediated cross protection against influenza"],"prefix":"10.1016","volume":"33","author":[{"given":"Marta","family":"Baranowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Hauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Hoornaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Bogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnveig","family":"Gr\u00f8deland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.08.094_bib0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1473-3099(02)00366-3","article-title":"Influenza\u2014WHO cares","volume":"2","author":"Stohr","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0315","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0320","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.it.2014.06.004","article-title":"T cell mediated immunity to influenza: mechanisms of viral control","volume":"35","author":"La Gruta","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0325","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0330","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/JVI.71.4.2715-2721.1997","article-title":"Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization","volume":"71","author":"Fu","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0335","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.175.2.481","article-title":"Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes","volume":"175","author":"Eisenlohr","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0345","doi-asserted-by":"crossref","first-page":"e1002381","DOI":"10.1371\/journal.ppat.1002381","article-title":"Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates","volume":"7","author":"Weinfurter","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0350","first-page":"417","article-title":"Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo","volume":"58","author":"Taylor","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0355","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.vaccine.2006.08.036","article-title":"Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice","volume":"25","author":"Kreijtz","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.08.094_bib0360","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02843-13","article-title":"Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus","volume":"88","author":"van de Sandt","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0365","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1099\/vir.0.033076-0","article-title":"Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells","volume":"92","author":"Hillaire","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2013.12.008","article-title":"High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination","volume":"151","author":"Tan","year":"2014","journal-title":"Clini Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0375","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0380","doi-asserted-by":"crossref","first-page":"e1002741","DOI":"10.1371\/journal.pcbi.1002741","article-title":"The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza","volume":"8","author":"Kucharski","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0385","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.vaccine.2005.08.105","article-title":"Antibody response to influenza vaccination in the elderly: a quantitative review","volume":"24","author":"Goodwin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0390","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1084\/jem.165.2.408","article-title":"Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes","volume":"165","author":"Gotch","year":"1987","journal-title":"J Exp Med"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2015.08.094_bib0395","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1099\/0022-1317-67-4-719","article-title":"Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes","volume":"67","author":"McMichael","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0400","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1126\/science.1227270","article-title":"Organization of the influenza virus replication machinery","volume":"338","author":"Moeller","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0405","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/JVI.10.4.795-800.1972","article-title":"Structure of the ribonucleoprotein of influenza virus","volume":"10","author":"Compans","year":"1972","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0410","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1099\/0022-1317-83-4-723","article-title":"The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication","volume":"83","author":"Portela","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0415","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.64.4.1487-1497.1990","article-title":"Evolution of the nucleoprotein gene of influenza A virus","volume":"64","author":"Gorman","year":"1990","journal-title":"J Virol"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2015.08.094_bib0420","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-70-8-2111","article-title":"Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses","volume":"70","author":"Altmuller","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0425","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0430","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","article-title":"Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA","volume":"72","author":"Ulmer","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0435","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2005.08.091","article-title":"Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge","volume":"24","author":"Breathnach","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0440","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0445","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.19109","article-title":"Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge","volume":"8","author":"Hashem","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0450","doi-asserted-by":"crossref","first-page":"e9812","DOI":"10.1371\/journal.pone.0009812","article-title":"Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret","volume":"5","author":"Rao","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0455","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/j.vaccine.2009.03.023","article-title":"Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses","volume":"27","author":"Patel","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0460","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-06-032938","article-title":"Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences","volume":"110","author":"Fredriksen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0465","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2005.10.019","article-title":"DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells","volume":"13","author":"Fredriksen","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0470","doi-asserted-by":"crossref","first-page":"e80008","DOI":"10.1371\/journal.pone.0080008","article-title":"The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype","volume":"8","author":"Grodeland","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0475","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.4049\/jimmunol.1300504","article-title":"DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza","volume":"191","author":"Grodeland","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0480","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0485","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.biocel.2003.10.019","article-title":"Macrophage inflammatory protein-1","volume":"36","author":"Maurer","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0490","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jim.2005.01.002","article-title":"Prolonged and increased expression of soluble Fc receptors, IgG and a TCR-Ig fusion protein by transiently transfected adherent 293E cells","volume":"298","author":"Berntzen","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0495","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0500","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.vaccine.2010.10.057","article-title":"Human chemokine MIP1alpha increases efficiency of targeted DNA fusion vaccines","volume":"29","author":"Ruffini","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0505","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","article-title":"Gene transfer into muscle by electroporation in vivo","volume":"16","author":"Aihara","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0510","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/mt.2009.120","article-title":"Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients","volume":"17","author":"Roos","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0515","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2006.10.002","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005\u20132006 season of dual A and B vaccine mismatch in Canada","volume":"25","author":"Skowronski","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0520","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.4049\/jimmunol.162.7.4163","article-title":"Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge","volume":"162","author":"Fu","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0525","doi-asserted-by":"crossref","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"Laidlaw","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0530","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/icb.2012.78","article-title":"Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses","volume":"91","author":"Grant","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0535","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0540","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0545","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"Lamere","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0550","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12026-007-0081-4","article-title":"T cell memory development: CD4 T cell help is appreciated","volume":"39","author":"Khanolkar","year":"2007","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0555","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2014.09.007","article-title":"CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection","volume":"41","author":"Laidlaw","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0560","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nature Med"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0565","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0570","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.smim.2004.02.004","article-title":"T cell responses to influenza infection","volume":"16","author":"Brown","year":"2004","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0575","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1128\/JVI.01631-14","article-title":"Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein","volume":"88","author":"Chen","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0580","first-page":"145","article-title":"Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant","volume":"36","author":"Cargnelutti","year":"2013","journal-title":"New Microbiol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0585","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4014\/jmb.1106.06021","article-title":"Improved immune response to recombinant influenza nucleoprotein formulated with ISCOMATRIX","volume":"22","author":"Cargnelutti","year":"2012","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0595","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0600","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0605","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/6995","article-title":"Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity","volume":"17","author":"Biragyn","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2015.08.094_bib0610","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1182\/blood-2005-08-3207","article-title":"Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses","volume":"107","author":"Schiavo","year":"2006","journal-title":"Blood"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15012761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15012761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T09:12:37Z","timestamp":1692004357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15012761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":61,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15012761"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8+-mediated cross protection against influenza","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.08.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}